Updated CPG: Community acquired needlestick injury
Community acquired needlestick injury was an existing Victorian CPG and will be considered for endorsement by PIC in April 2021. The revision was considered by the CPG committee on 15 June 2020.
Newsletter
Updated CPG: Acute asthma
Acute asthma was an existing Victorian CPG and was endorsed by PIC on 18 February 2021. The revision was considered by interstate reviewers.
Updated CPG: Henoch-Schönlein purpura
Henoch-schönlein purpura was an existing Victorian CPG and was endorsed by PIC on 18 February 2021. The revision was considered by interstate reviewers.
New CPG: Nasogastric fluids
Nasogastric fluids is a new CPG and was endorsed by PIC on 18 February 2021. The guideline was discussed by the CPG committee on 21 October 2020.
Updated CPG: Gastroenteritis
Gastroenteritis is an existing Victorian CPG and was endorsed by PIC on 18 February 2021. The guideline was discussed by the CPG committee on 5 November 2020.
New CPG: Vomiting
Vomiting is a new CPG and was endorsed by PIC on 18 February 2021. The guideline was discussed by the CPG committee on 16 September 2020.
Updated CPG: Sodium valproate poisoning
Sodium valproate poisoning was an existing Victorian CPG and was endorsed by PIC on 18 February 2021. The revision was considered by interstate reviewers.
Updated CPG: Kawasaki disease
Kawasaki Disease was an existing Victorian CPG and was endorsed by PIC on 18 February 2021. The revision was discussed by the CPG committee on 1 October 2020.
Updated CPG: Febrile seizure
Febrile seizure was an existing Victorian CPG and was endorsed by PIC on 18 February 2021. The revision was considered by interstate reviewers.
New CPG: Oral hypoglycaemic poisoning
Oral hypoglycaemic poisoning is a new CPG that was endorsed for Victorian use on 18 February 2021 and requires consideration by interstate reviewers before endorsement by PIC.